“Mary’s has developed a line of unique products with unparalleled quality, accuracy and an exceptional reputation for effectiveness,” said Ben Kovler, Founder and Chairman, GTI. “Patients deserve the choice of alternative forms of medical cannabis and we’re excited to bring this trusted, revolutionary, and highly-targeted suite of medical cannabis delivery options to the patients of Maryland. The patients in Illinois have had tremendous success with Mary’s and we look forward to providing the same access, options, and relief to thousands more.”
Mary’s Medicinals has established itself as one of the most trusted and innovative producers of canna-based products in Colorado, and has since expanded into additional states from coast to coast. Mary’s was first to offer THCa and CBN products, discovered harvesting techniques for the isolation of CBC, and continues to develop cutting edge approaches for isolating, manufacturing and delivering medicinal cannabis.
“The potential of cannabinoid therapies as a treatment for many conditions is enormous. However, the traditional cannabis products on the market today don’t appeal to all patients,” said Lynn Honderd, CEO of Mary’s Medicinals. “With Mary’s unique delivery and accurate dosing mechanisms, patients are finding relief that is more effective, more reliable and more targeted than anything else available. We’re pleased to expand our relationship with the highly-regarded and qualified team at GTI to help bring relief to the patients of Maryland.”